CCI-779 in Treating Patients With Prostate Cancer

NCT00012142 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: temsirolimus

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]